Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New injection offers hope for severe asthma sufferers
Disease control Recruiting nowThis study is testing whether adding a new drug called GB-0895 helps people with severe asthma that isn't controlled by their usual high-dose inhalers. About 786 participants, aged 12 to 80, will receive either GB-0895 or a placebo injection every six months for a year to see if …
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New shot offers hope for severe asthma sufferers
Disease control Recruiting nowThis study is testing if a new drug called GB-0895 can help people with severe asthma that isn't well-controlled by their current medications. About 786 adults and teens will receive either the new drug or a placebo as a shot every six months for a year. The main goal is to see i…
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC